Here's Why Investors Should Retain ResMed (RMD) Stock for Now
https://www.zacks.com/stock/news/2196711/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196711
Dec 12, 2023 - Investors continue to be optimistic about ResMed (RMD) due to the sustained growth in the SaaS business.
0
Here's Why You Should Retain Surmodics (SRDX) Stock for Now
https://www.zacks.com/stock/news/2196894/here-s-why-you-should-retain-surmodics-srdx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196894
Dec 12, 2023 - Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
0
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
https://www.zacks.com/stock/news/2196582/reasons-to-add-cardinal-health-cah-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196582
Dec 12, 2023 - Cardinal Health (CAH) continues to gain traction from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
0
Thermo Fisher (TMO) Launches New Solutions for Clinical Labs
https://www.zacks.com/stock/news/2196649/thermo-fisher-tmo-launches-new-solutions-for-clinical-labs?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196649
Dec 12, 2023 - Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.
0
Medtronic (MDT) Expands AI-Driven Care With New Partnership
https://www.zacks.com/stock/news/2197563/medtronic-mdt-expands-ai-driven-care-with-new-partnership?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2197563
Dec 13, 2023 - Medtronic's (MDT) expanded collaboration with Cosmo Pharmaceuticals is a strategic step forward in its quest to use AI to improve patient care.
0
Here's Why You Should Retain McKesson (MCK) Stock for Now
https://www.zacks.com/stock/news/2197165/here-s-why-you-should-retain-mckesson-mck-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197165
Dec 13, 2023 - McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
0
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
https://www.zacks.com/stock/news/2197789/here-s-why-you-should-retain-glaukos-gkos-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197789
Dec 14, 2023 - Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
0
Here's Why You Should Retain Catalent (CTLT) Stock for Now
https://www.zacks.com/stock/news/2198761/here-s-why-you-should-retain-catalent-ctlt-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2198761
Dec 15, 2023 - Catalent's (CTLT) products and services portfolio and technology foundation raise optimism about the stock.
0
Align's (ALGN) New Launches Aid, Macroeconomic Woes Linger
https://www.zacks.com/stock/news/2198721/align-s-algn-new-launches-aid-macroeconomic-woes-linger?cid=CS-ZC-FT-analyst_blog|zer_report_update-2198721
Dec 15, 2023 - Align Technology (ALGN) performs digital treatment planning and interpretation for restorative cases worldwide, including Costa Rica, China, Germany, Spain, Poland and Japan, among others.
0
Neogen (NEOG) to Advance Feline DNA Testing With New Pact
https://www.zacks.com/stock/news/2198888/neogen-neog-to-advance-feline-dna-testing-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2198888
Dec 15, 2023 - Neogen's (NEOG) strategic alliance will expand feline DNA testing and strengthen its relationship with the kitty community.
0